Page last updated: 2024-10-24

busulfan and Multiple Primary Neoplasms

busulfan has been researched along with Multiple Primary Neoplasms in 7 studies

Research Excerpts

ExcerptRelevanceReference
"Acute non-lymphocytic leukemia occurred in eight women following long-term treatment with Treosulfan (= dihydroxybusulfan) for ovarian carcinoma."7.66Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). ( Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM, 1980)
"Acute non-lymphocytic leukemia occurred in eight women following long-term treatment with Treosulfan (= dihydroxybusulfan) for ovarian carcinoma."3.66Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). ( Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM, 1980)
"Chlorambucil and melphalan were the most leukemogenic drugs, followed by thiotepa; cyclophosphamide and treosulfan were the weakest leukemogens, and the effect per gram was substantially lower at high doses than at lower doses."2.67Leukemia following chemotherapy for ovarian cancer. ( Bell, J; Clarke, EA; Day, NE; Høst, H; Kaldor, JM; Karjalainen, S; Mehnert, W; Pedersen, D; Pettersson, F; Prior, P, 1990)
"A patient with acute myeloblastic leukemia received high-dose busulfan (1 mg/kg by mouth every 6 h for 4 days) as myelo-ablative therapy for autologous bone marrow transplantation."1.28Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy. ( Ehrsson, H; Hassan, M; Oberg, G; Simonsson, B; Smedmyr, B; Tötterman, T; Wallin, I, 1989)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedersen-Bjergaard, J1
Nissen, NI1
Sørensen, HM1
Hou-Jensen, K1
Larsen, MS1
Ernst, P1
Ersbøl, J1
Knudtzon, S1
Rose, C1
Stott, H2
Fox, W2
Girling, DJ2
Stephens, RJ2
Galton, DA1
Kaldor, JM1
Day, NE1
Pettersson, F1
Clarke, EA1
Pedersen, D1
Mehnert, W1
Bell, J1
Høst, H1
Prior, P1
Karjalainen, S1
Papineschi, F1
Bonini, R1
Pistolisi, D1
Spremolla, G1
Hassan, M1
Ehrsson, H1
Smedmyr, B1
Tötterman, T1
Wallin, I1
Oberg, G1
Simonsson, B1
Firusian, N1
Reis, HE1
Gallmeier, W1
Schmidt, CG1

Trials

3 trials available for busulfan and Multiple Primary Neoplasms

ArticleYear
Acute leukaemia after busulphan.
    British medical journal, 1977, Dec-10, Volume: 2, Issue:6101

    Topics: Acute Disease; Bronchial Neoplasms; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Hu

1977
Leukemia following chemotherapy for ovarian cancer.
    The New England journal of medicine, 1990, Jan-04, Volume: 322, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Case-Control Studie

1990
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
    British journal of cancer, 1985, Volume: 52, Issue:6

    Topics: Aged; Busulfan; Carcinoma, Bronchogenic; Clinical Trials as Topic; Combined Modality Therapy; Cyclop

1985

Other Studies

4 other studies available for busulfan and Multiple Primary Neoplasms

ArticleYear
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
    Cancer, 1980, Jan-01, Volume: 45, Issue:1

    Topics: Adult; Aged; Busulfan; Chromosome Aberrations; Female; Humans; Leukemia; Middle Aged; Neoplasms, Mul

1980
[Chronic myeloid leukemia and carcinoma of the prostate].
    Sangre, 1989, Volume: 34, Issue:5

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Busulfan; Cyproterone; Cyproterone Acetate; Humans; Leuk

1989
Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy.
    Bone marrow transplantation, 1989, Volume: 4, Issue:1

    Topics: Bone Marrow Transplantation; Busulfan; Half-Life; Humans; Leukemia, Myeloid, Acute; Male; Middle Age

1989
[Syntropy of malignant diseases with hemoblastosis].
    Medizinische Klinik, 1970, Nov-27, Volume: 65, Issue:48

    Topics: Adenocarcinoma; Aged; Busulfan; Estradiol; Female; Humans; Immunosuppressive Agents; Kidney Neoplasm

1970